BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12774007)

  • 1. All liver recipients benefit from the protocol 10-year liver biopsies.
    Sebagh M; Rifai K; Féray C; Yilmaz F; Falissard B; Roche B; Bismuth H; Samuel D; Reynès M
    Hepatology; 2003 Jun; 37(6):1293-301. PubMed ID: 12774007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
    Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft and systemic disease in long-term survivors of liver transplantation.
    Slapak GI; Saxena R; Portmann B; Gane E; Devlin J; Calne R; Williams R
    Hepatology; 1997 Jan; 25(1):195-202. PubMed ID: 8985290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
    Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
    Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
    Heneghan MA; Zolfino T; Muiesan P; Portmann BC; Rela M; Heaton ND; O'grady JG
    Liver Transpl; 2003 Sep; 9(9):921-8. PubMed ID: 12942453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
    J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor age influences 10-year liver graft histology independently of hepatitis C virus infection.
    Rifai K; Sebagh M; Karam V; Saliba F; Azoulay D; Adam R; Castaing D; Bismuth H; Reynès M; Samuel D; Féray C
    J Hepatol; 2004 Sep; 41(3):446-53. PubMed ID: 15336448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.
    Sebagh M; Samuel D; Antonini TM; Coilly A; Degli Esposti D; Roche B; Karam V; Dos Santos A; Duclos-Vallée JC; Roque-Afonso AM; Ballot E; Guettier C; Blandin F; Saliba F; Azoulay D
    J Hepatol; 2012 Apr; 56(4):840-7. PubMed ID: 22173152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers.
    Krasinskas AM; Demetris AJ; Poterucha JJ; Abraham SC
    Liver Transpl; 2008 May; 14(5):625-32. PubMed ID: 18433038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation].
    Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
    Nephrol Ther; 2005 Dec; 1(6):345-54. PubMed ID: 16895705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.